Przejdź do zawartości
Merck

Novel PNKP mutations causing defective DNA strand break repair and PARP1 hyperactivity in MCSZ.

Neurology. Genetics (2019-05-02)
Ilona Kalasova, Hana Hanzlikova, Neerja Gupta, Yun Li, Janine Altmüller, John J Reynolds, Grant S Stewart, Bernd Wollnik, Gökhan Yigit, Keith W Caldecott
ABSTRAKT

To address the relationship between novel mutations in polynucleotide 5'-kinase 3'-phosphatase (PNKP), DNA strand break repair, and neurologic disease. We have employed whole-exome sequencing, Sanger sequencing, and molecular/cellular biology. We describe here a patient with microcephaly with early onset seizures (MCSZ) from the Indian sub-continent harboring 2 novel mutations in PNKP, including a pathogenic mutation in the fork-head associated domain. In addition, we confirm that MCSZ is associated with hyperactivation of the single-strand break sensor protein protein poly (ADP-ribose) polymerase 1 (PARP1) following the induction of abortive topoisomerase I activity, a source of DNA strand breakage associated previously with neurologic disease. These data expand the spectrum of PNKP mutations associated with MCSZ and show that PARP1 hyperactivation at unrepaired topoisomerase-induced DNA breaks is a molecular feature of this disease.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Anti-pan-ADP-ribose binding reagent, from Escherichia coli
Sigma-Aldrich
Anti-p53 (Ab-3) (Mutant) Mouse mAb (PAb240), liquid, clone PAb240, Calbiochem®